MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Pfizer

Cerrado

Sector Salud

26.32 1.86

Resumen

Variación precio

24h

Actual

Mínimo

25.84

Máximo

26.56

Métricas clave

By Trading Economics

Ingresos

-4.1B

410M

Ventas

63M

18B

P/B

Media del Sector

18.362

73.394

BPA

0.63

Rentabilidad por dividendo

6.64

Margen de beneficio

2.308

EBITDA

-6.1B

729M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+19.42 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.64%

3.09%

Próximas Ganancias

30 abr 2025

Fecha Próximo Dividendo

7 mar 2025

Próxima Fecha de Ex Dividendo

8 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-4.5B

147B

Apertura anterior

24.46

Cierre anterior

26.32

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

143 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

Pfizer Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 feb 2025, 18:52 UTC

Principales Movimientos del Mercado

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

4 feb 2025, 14:58 UTC

Ganancias
Principales Movimientos del Mercado

Pfizer Shares Rise on Better-Than-Expected 4Q

4 feb 2025, 12:24 UTC

Ganancias

Pfizer 4Q Revenue Beat Leads to Swing to Profit

24 ene 2025, 22:56 UTC

Principales Noticias

Pfizer to Pay $60 Million in Kickback, False Claims Settlement

15 ene 2025, 07:57 UTC

Adquisiciones, fusiones, absorciones

Pfizer Sells 700 Million Haleon Shares for $3.05 Billion

14 ene 2025, 17:16 UTC

Adquisiciones, fusiones, absorciones

Pfizer to Cut Haleon Stake

14 feb 2025, 11:38 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb 2025, 11:30 UTC

Principales Noticias
Ganancias

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb 2025, 12:00 UTC

Principales Noticias

Merck Is Suffering From a Classic Pharma Problem -- Heard on the Street -- WSJ

4 feb 2025, 19:34 UTC

Principales Noticias

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 feb 2025, 19:10 UTC

Principales Noticias

Pfizer Falls on RFK's Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. -- Barrons.com

4 feb 2025, 18:51 UTC

Principales Noticias

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

4 feb 2025, 14:12 UTC

Principales Noticias
Ganancias

Update: Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance -- Barrons.com

4 feb 2025, 12:10 UTC

Principales Noticias
Ganancias

Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance -- Barrons.com

4 feb 2025, 12:09 UTC

Ganancias

Pfizer Stock Climbs On Q4 Revenue And Earnings Beat, Reaffirmed Guidance -- MarketWatch

4 feb 2025, 11:51 UTC

Ganancias

Pfizer Sees FY25 Adjusted R&D Expenses $10.7B - $11.7B >PFE

4 feb 2025, 11:48 UTC

Ganancias

Pfizer On Track to Deliver Overall Net Cost Savings of About $4.5B by End of 2025 From Ongoing Cost Realignment Program >PFE

4 feb 2025, 11:48 UTC

Ganancias

Pfizer Expects to Sufficiently De-Lever Balance Sheet by End of 2025 to Return to More Balanced Cap Allocation Strategy >PFE

4 feb 2025, 11:47 UTC

Ganancias

Pfizer Sees FY25 Adj EPS $2.80-Adj EPS $3.00 >PFE

4 feb 2025, 11:47 UTC

Ganancias

Pfizer Sees FY25 Rev $61.0B-$64.0B >PFE

4 feb 2025, 11:45 UTC

Ganancias

Pfizer 4Q Adj EPS 63c >PFE

4 feb 2025, 11:45 UTC

Ganancias

Pfizer 4Q Rev $17.8B >PFE

4 feb 2025, 11:45 UTC

Ganancias

Pfizer 4Q EPS 7c >PFE

4 feb 2025, 10:01 UTC

Acciones populares

Stocks to Watch Tuesday: Alphabet, Diageo, PDD -- WSJ

29 ene 2025, 16:56 UTC

Principales Noticias

RFK Jr. Hearing Kicks Off With Nomination Under Fire -- Barrons.com

29 ene 2025, 15:14 UTC

Principales Noticias

RFK Jr. Hearing Kicks Off With Nomination Under Fire -- Barrons.com

28 ene 2025, 10:30 UTC

Principales Noticias

Drug Companies Raise Prices on More Than 800 Drugs in January -- WSJ

24 ene 2025, 22:41 UTC

Principales Noticias

Pfizer to Pay $60M in Kickback, False Claims Settlement

20 ene 2025, 12:00 UTC

Principales Noticias

Beaten Down Under Biden, Big Pharma Hopes for New Chapter Under Trump -- Heard on the Street -- WSJ

6 ene 2025, 12:00 UTC

Principales Noticias

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

Comparación entre iguales

Cambio de precio

Pfizer Esperado

Precio Objetivo

By TipRanks

19.42% repunte

Estimación a 12 meses

Media 30.93 USD  19.42%

Máximo 36 USD

Mínimo 28 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

17 ratings

7

Comprar

10

Mantener

0

Vender

Puntuación técnica

By Trading Central

25.51 / 25.9599Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

143 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.